Larginus
General properties
Agents affecting cardio-vascular system.
Use for the combination therapy of atherosclerosis of brain- and heart-supplying arteries, arterial hypertension, atherosclerosis of peripheral vessels; chronic heart failure; hypercholesterolemia; chronic obstructive pulmonary diseases, pulmonary hypertension; asthenic conditions.Use for the combination therapy of atherosclerosis of brain- and heart-supplying arteries, arterial hypertension, atherosclerosis of peripheral vessels; chronic heart failure; hypercholesterolemia; chronic obstructive pulmonary diseases, pulmonary hypertension; asthenic conditions.
Hypersensitivity, severe renal dysfunctions. Myocardial infarction (including in the medical history).
Pharmaceutical characteristics
Off-white liquid with the caramel odor.
Store in the original packaging at a temperature not exceeding 25 °C. Keep out of reach of children. Do not freeze.
